The Frontiers in Oncology lecture series brings outstanding investigators involved in cancer research to the UMGCCC campus each month. The series is designed to educate and provide exposure to the latest developments in cancer biology, treatment and diagnosis. Topics will be of interest to faculty members, oncologists, medical interns, nurses, pharmacologists and research fellows.

When: 3rd Tuesday of every month, 9 am

Where: Zoom

CME Credit: One (1)

Contact: 410-328-7516, Note: If you would like to meet with the speaker, please contact Florence Wade.

Upcoming Frontiers in Oncology Seminars

September 21, 2021 – 9:00 am – Zoom Virtual Seminar

Stefan Ambs, PhD, MPH

Senior Investigator and Head
Molecular Epidemiology Section
Laboratory of Human Carcinogenesis
National Cancer Institute
National Institutes of Health
Bethesda, MD

"An Investigation of How Inflammation and the Immune Response May Underlie the Excessive Burden of Prostate Cancer in Men of African Ancestry"

October 18, 2021 – 9:00 am – Zoom Virtual Seminar

Shrikant Anant, PhD

Kansas Mason Professor and Chair
Department of Cancer Biology
Tom & Teresa Walsh Professor of Cancer Prevention
Associate Director, Basic Science
NCI-Designated Kansas University Cancer Center
Kansas City, KS

"Prolactin Signaling: A Therapeutic Target to Suppress Pancreatic Cancer"

November 16, 2021 – 9:00 am – Leadership Hall, MSTF Building, 2nd Floor

Jiaoti Huang, MD, PhD

Distinguished University Professor
Johnston and West Endowed Chair
Chairman, Department of Pathology
Duke University School of Medicine
Durham, NC

"Neuroendocrine Differentiation of Prostate Cancer"

December 21, 2021 – 9:00 am – Zoom Virtual Seminar

Mitchell Ho, PhD

Senior Investigator
Head, Antibody Therapy Session
Deputy Chief, Laboratory of Molecular Biology
Director, Antibody Engineering Program
National Cancer Institute
National Institute of Health
Bethesda, MD

"Glypicans as Solid Tumor Targets for CAR T Cell Therapy"

High Performing Hospitals | US News & World Report | 2021-22 | Cancer